Carregant...
Withdrawal effects confounding in clinical trials: another sign of a needed paradigm shift in psychopharmacology research
Randomized controlled trials’ ability to produce evidence useful for people to decide whether to take, continue taking, or stop taking psychotropic drugs has been intensely critiqued, along with the trials’ commercial, ideological, and regulatory contexts. This article applies the critique to the to...
Guardat en:
| Publicat a: | Ther Adv Psychopharmacol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7656873/ https://ncbi.nlm.nih.gov/pubmed/33224467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125320964097 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|